Aardvark Therapeutics appoints Derrick C. Li as chief business officer
Source: SeekingAlpha
2026-02-12 08:48:06 ET
More on Aardvark Therapeutics
- Seeking Alpha’s Quant Rating on Aardvark Therapeutics
- Historical earnings data for Aardvark Therapeutics
- Financial information for Aardvark Therapeutics
Read the full article on Seeking Alpha
For further details see:
Aardvark Therapeutics appoints Derrick C. Li as chief business officer
Aardvark Therapeutics Inc.
NASDAQ: AARD
AARD Trading
-7.73% G/L:
$5.255 Last:
76,271 Volume:
$5.25 Open:
AARD Latest News
February 28, 2026 11:46:00 am
AARD Investors Have Opportunity to Join Aardvark Therapeutics, Inc. Fraud Investigation With the Schall Law Firm
February 27, 2026 04:05:00 pm
Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome
AARD Stock Data
$274,560,960
11,561,607
7.81%
13
N/A
Pharmaceuticals
Healthcare
US
San Diego
